Qlosi滴眼液的功效与作用

The original research company of Qlosi eye drops is Orasis Pharmaceuticals, which was approved by the US FDA for marketing in October 2023.

Indications and Applicable Populations of Qlosi Eye Drops

1. Indications

It is suitable for the treatment of adult presbyopia, which is a common phenomenon in which vision adjustment ability decreases with age, resulting in blurred vision at close range.

2. Applicable population

Adults aged between 45 and 64 years old. Clinical research is mainly targeted at this age group. Not suitable for children and teenagers as presbyopia is an age-related disease.

Efficacy and effects of Qlosi eye drops

Pilocarpine in Qlosi eye drops is a cholinergic agonist that activates muscarinic receptors on the iris sphincter and ciliary muscle, which can contract the pupil, enhance the depth of field, and improve near vision, while retaining part of the pupil's ability to respond to light.

The pictures come from public channels (such as the official website of the FDA, the official website of the original drug manufacturer, etc.) and are for reference only.

Qlosi Eye Drops Usage and Dosage Guide

1. Routine administration: Instill 1 drop of Qlosi Eye Drops into each eye

times. If you need to extend the effect to 8 hours, instill 1 drop (per eye) again 2-3 hours after the first dose.

2. Frequency of administration

It can be administered regularly every day, or as needed according to the patient's vision needs. The maximum number of administrations per day is no more than 2 times (that is, a maximum of 2 drops per eye per day).

3. Combined medication interval

If multiple topical ophthalmic drugs need to be used at the same time, the administration interval between different drugs must be at least 5 minutes to prevent the later-administered drugs from washing out the first-administered drugs and affecting the efficacy.

4. Use of single-dose bottles

Qlosi eye drops are packaged for single-patient use. Each single-dose bottle can only be used once after opening. The remaining liquid must be discarded immediately and cannot be retained or used by others to prevent eye infection or liquid contamination.

Important Precautions for Qlosi Eye Drops

1. Blurred Vision and Driving Safety

Temporary blurred vision or decreased dark vision may occur after using Qlosi Eye Drops. It is recommended not to drive, operate machines, or engage in night activities until your vision is clear.

2. Risk of retinal detachment

A very small number of patients develop retinal detachment after using miotic drugs. It is recommended to conduct a retinal examination before use. If flashes, floaters or sudden loss of vision occur, seek medical attention immediately.

3. Use with caution in special groups

Patients who have experienced iritis should be used with caution to avoid iris adhesion or even more serious complications during treatment. In addition, Qlosi eye drops are contraindicated in those who are allergic to pilocarpine or any of its ingredients.